These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28927189)

  • 1. Scientific, societal, and economic consequences of releasing interim data from clinical trials.
    Sharma A; Bigelow RH; Pencina MJ
    Eur Heart J Qual Care Clin Outcomes; 2017 Jan; 3(1):9-10. PubMed ID: 28927189
    [No Abstract]   [Full Text] [Related]  

  • 2. A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials.
    Fernandes RM; van der Lee JH; Offringa M
    BMC Pediatr; 2009 Dec; 9():77. PubMed ID: 20003383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the independence of data monitoring committee in adaptive design clinical trials.
    Chow SC; Corey R; Lin M
    J Biopharm Stat; 2012; 22(4):853-67. PubMed ID: 22651119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent data monitoring committees: an update and overview.
    Sartor O; Halabi S
    Urol Oncol; 2015 Mar; 33(3):143-8. PubMed ID: 25631301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting on data monitoring committees in neonatal randomised controlled trials is inconsistent.
    Perrem LM; Gosling S; Ravikumar I; Khashan AS; Miletin J; Ryan CA; Dempsey E
    Acta Paediatr; 2017 Jan; 106(1):30-33. PubMed ID: 27637413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Framework for Retrospective Assessment of Interim Decisions in Clinical Trials.
    Stanev R
    Med Decis Making; 2016 Nov; 36(8):999-1010. PubMed ID: 27353825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
    Zhao Y; Grambsch PM; Neaton JD
    Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When should data and safety monitoring committees share interim results in cardiovascular trials?
    Borer JS; Gordon DJ; Geller NL
    JAMA; 2008 Apr; 299(14):1710-2. PubMed ID: 18398083
    [No Abstract]   [Full Text] [Related]  

  • 9. Interim monitoring of clinical trials.
    Richardson D
    Front Neurol Neurosci; 2009; 25():127-130. PubMed ID: 19478510
    [No Abstract]   [Full Text] [Related]  

  • 10. Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study.
    Sydes MR; Altman DG; Babiker AB; Parmar MK; Spiegelhalter DJ;
    Clin Trials; 2004 Feb; 1(1):48-59. PubMed ID: 16281462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the Scientific Integrity and Safety of Clinical Trials: Recommendations for Data Monitoring Committees.
    Lewis RJ; Calis KA; DeMets DL
    JAMA; 2016 Dec; 316(22):2359-2360. PubMed ID: 27960001
    [No Abstract]   [Full Text] [Related]  

  • 12. Data monitoring committees for pragmatic clinical trials.
    Ellenberg SS; Culbertson R; Gillen DL; Goodman S; Schrandt S; Zirkle M
    Clin Trials; 2015 Oct; 12(5):530-6. PubMed ID: 26374679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the functions and operations of data monitoring committees: Survey and focus group findings.
    Calis KA; Archdeacon P; Bain RP; Forrest A; Perlmutter J; DeMets DL
    Clin Trials; 2017 Feb; 14(1):59-66. PubMed ID: 27885056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Futility approaches to interim monitoring by data monitoring committees.
    Demets DL
    Clin Trials; 2006; 3(6):522-9. PubMed ID: 17170036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary: preserving confidentiality of interim data.
    Chuang-Stein C; Jiang Q; Marchenko O
    Clin Trials; 2015 Feb; 12(1):18-20. PubMed ID: 25480540
    [No Abstract]   [Full Text] [Related]  

  • 16. Conditions for making trial data available to other investigators.
    Bion JF
    BMJ; 2016 Mar; 352():i1573. PubMed ID: 27001258
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary: confidentiality of interim trial data-the emerging crisis.
    Nissen SE
    Clin Trials; 2015 Feb; 12(1):15-7. PubMed ID: 25525072
    [No Abstract]   [Full Text] [Related]  

  • 18. Threat of interim data leaks prompts call for international rules.
    Bloudoff-Indelicato M
    Nat Med; 2015 Mar; 21(3):200. PubMed ID: 25742445
    [No Abstract]   [Full Text] [Related]  

  • 19. Where's the utility in Bayesian data-monitoring of clinical trials?
    Ashby D; Tan SB
    Clin Trials; 2005; 2(3):197-205; discussion 205-8. PubMed ID: 16279143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The independent statistician for data monitoring committees.
    DeMets DL; Fleming TR
    Stat Med; 2004 May; 23(10):1513-7. PubMed ID: 15122729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.